Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nu-Med PlusNUMD 3-Year Share Buyback Ratio is -0.90 as of Mar. 2026. The stock has 1 warning sign investors should review. Among 614 Medical Devices & Instruments companies, Nu-Med Plus ranks better than 62.54% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Nu-Med Plus's current 3-Year Share Buyback Ratio was -0.90%.
The historical rank and industry rank for Nu-Med Plus's 3-Year Share Buyback Ratio or its related term are showing as below:
NUMD'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -24.3 Med: -8 Max: -0.9
Current: -0.9
During the past 13 years, Nu-Med Plus's highest 3-Year Share Buyback Ratio was -0.90%. The lowest was -24.30%. And the median was -8.00%.
NUMD's 3-Year Share Buyback Ratio is ranked better than 62.54% of 614
companies
in the Medical Devices & Instruments industry
Industry Median: -2.65
vs NUMD: -0.90
Nu-Med Plus (OTCPK:NUMD) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Nu-Med Plus 3-Year Share Buyback Ratio Related Terms
NUMD vs SSKN, ODYY, NUWE: 3-Year Share Buyback Ratio Comparison
For the Medical Devices subindustry, Nu-Med Plus's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nu-Med Plus 3-Year Share Buyback Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nu-Med Plus's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Nu-Med Plus's 3-Year Share Buyback Ratio falls into.
Nu-Med Plus 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of -0.90 mean?
Nu-Med Plus (NUMD) has a 3-Year Share Buyback Ratio of -0.90 as of Mar. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Nu-Med Plus and its competitors. According to the industry distribution chart, Nu-Med Plus ranks #230 out of 614 companies in the Medical Devices & Instruments industry, placing it in the top 37.5%.
Is Nu-Med Plus' 3-Year Share Buyback Ratio too high?
Nu-Med Plus' current 3-Year Share Buyback Ratio is -0.90. Based on the distribution chart, Nu-Med Plus ranks #230 out of 614 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does Nu-Med Plus' 3-Year Share Buyback Ratio compare to SSKN and ODYY?
According to the Medical Devices & Instruments industry distribution chart, Nu-Med Plus ranks #230 out of 614 companies for 3-Year Share Buyback Ratio. This puts Nu-Med Plus in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Nu-Med Plus and its competitors. Nu-Med Plus's current 3-Year Share Buyback Ratio is -0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nu-Med Plus stock overvalued right now?
Nu-Med Plus (NUMD) has a current 3-Year Share Buyback Ratio of -0.90. The current 3-Year Share Buyback Ratio is -0.90. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Nu-Med Plus (NUMD), the current 3-Year Share Buyback Ratio is -0.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nu-Med Plus Inc is a medical device company engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems, and the medical community throughout the world. It is currently working to locate a merger partner that will be able to fund the final development of these products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUMD has been successfully added to your 
